Skip to main content


June 15, 2020
Targeted chemo is feasible, safe, and may improve quality of life.
September 23, 2018
Older age or a higher rate of comorbidities with age do not affect survival in metastatic colorectal cancer when patients receive radiofrequency ablation, high-dose-rate brachytherapy, or Y90-radioembolization, according to a study published in BMC…
September 18, 2018
The mutational status and histopathologic grade of patients with chemorefractory colorectal liver metastases (CRLM) may predict survival after Y90 radioembolization therapy, according to a study published in Oncotarget.
September 16, 2018
Using 3D voxel-based dosimetry in patients with hepatocellular carcinoma treated by yttrium-90 resin microspheres radioembolization, a new study determined that complete tumor targeting and 90Y dose to tumor are independent factors associated with…
September 09, 2018
According to a new study, 90Y transarterial radioembolization around immunotherapy is safe and effective and the combined treatment may improve hepatic progression-free survival and overall survival in patients with hepatic metastases from uveal…
September 05, 2018
In an exploratory case of a patient with metastatic colorectal cancer, a hotspot panel of cancer-associated gene mutations was used to identify tumor-specific mutations.
September 03, 2018
Tumor response can be predicted after 90Y radioembolization in patients with HCC by analyzing the delivered tumoral radiation dose by PET dosimetry.
August 25, 2018
A recent study looked at the potential effectiveness of genomic profiling into predicting radioembolization outcome in patients with breast cancer metastatic to the liver with PI3K pathway mutation.
August 19, 2018
A new study compared overall survival for patients with early-stage non–small cell lung cancer treated with either radiofrequency ablation or stereotactic body radiotherapy.
August 14, 2018
Patients with small renal masses who are poor candidates for nephron-sparing surgery may benefit from radiofrequency ablation performed percutaneously.
August 14, 2018
Results of a retrospective review found that biopsy results of renal masses rarely obviated the need for subsequent ablation and can safely be performed alongside image-guided tumor ablation.
Back to Top